Post Title

The DigitalHealth.London and Cedars-Sinai Accelerators, two of the world’s top Accelerator programmes, today announced their new partnership supporting the international adoption of some of the US and UK’s best health tech companies.

It means patients in both the UK and US should benefit quicker from health tech innovations. The partnership will also utilise the deep healthcare knowledge and networks held by both organisations, to support companies who have taken part in either of the Accelerator programmes, to navigate and gain traction in a new global market. The companies will be given the opportunity to learn from and support their global peers, hear from experts in the new market, showcase their products/services to key international stakeholders and attend webinars on the respective healthcare systems.

Jenny Thomas, Programme Director, DigitalHealth.London, said: “At DigitalHealth.London we are dedicated to supporting the growth and development of high potential digital health companies who are meeting the challenges facing health care systems today. The Cedars-Sinai Accelerator shares this goal, and it is our joint vision to work together to accelerate the adoption of the best healthcare solutions internationally.”

Anne Wellington, Managing Director, Cedars-Sinai Accelerator, said: “The Cedars-Sinai Accelerator supports innovation that will improve healthcare, not only for our own patients and clinicians but by advancing technologies that benefit our global community. We are thrilled that this collaboration with DigitalHealth.London will foster support and adoption of the most transformative solutions from the US and UK!.”

Dr Tim Ferris, Director of Transformation at NHSE, said: “Some of the world’s most exciting digital health work is happening here in the UK. The NHS has a lot of knowledge to share, and there is also much we can learn from other countries. It is vital we use these connections to promote effective ways of improving patient care and work environments for busy NHS staff.”

DigitalHealth.London’s Accelerator aims to speed up the adoption of technology in London’s NHS, relieving high pressure on services and empowering patients to manage their health. It works with up to 20 SMEs over a 12-month period, giving bespoke support and advice, a programme of expert-led workshops and events and brokering meaningful connections between innovators and NHS organisations with specific challenges. The NHS delivered programme, funded in part by the European Regional Development Fund, has supported some of the biggest and most effective digital innovations now being used by the NHS in London. Companies including LIVI, Oxehealth, Patchwork Health, Echo, Sweatcoin, and Health Navigator have all been through the DigitalHealth.London Accelerator programme. To date, the Accelerator has supported 122 innovative digital health companies, with 591 additional contracts secured and 1498 jobs created by those companies during Accelerator support. £2.06 billion of investment has been raised by these companies to date and for every £1 spent on the programme through the AHSNs, it is estimated £12.70 is saved for the NHS*.

The Cedars-Sinai Accelerator is transforming healthcare quality, efficiency, and care delivery by helping entrepreneurs create, grow and scale their innovative technology products. This three-month program, based in Los Angeles, California, provides companies with $100,000 in funding, mentorship from more than 300 leading clinicians and executives, access to Cedars-Sinai, and exposure to a broad network of entrepreneurs and investors. Since 2015, the Accelerator has helped more than 60 companies transform healthcare delivery and patient care. Examples of companies supported by the Accelerator include WELL Health, Aiva Health, Health Note, Diligent Robotics and AppliedVR. UK-founded alumni of the Cedars-Sinai Accelerator include Lumeon, Lantum and Virti. Accelerator alumni have gone on to collectively raise more than $500M in investment and are in use at thousands of hospitals and clinics across the United States and around the world.